Kimber Taylor, FNP-C

Kimber Taylor practices at American Oncology Partners PA in Asheville, North Carolina.

Kimber Taylor's NPI, 1801668017, was assigned on October 23, 2023. Kimber Taylor holds Nevada license 842271.

Kimber Taylor's primary practice is American Oncology Partners PA, at 551 Brevard Rd, Asheville, NC 28806 in Buncombe County. The practice phone is (614) 383-6000.

Kimber Taylor's primary practice is American Oncology Partners PA in Asheville, North Carolina. Kimber Taylor is also affiliated with UCHealth Memorial Hospital Central. The medical group on file is Zangmeister Cancer Center. Dmand AI also links Kimber Taylor to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kimber Taylor practices, 2 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Kimber Taylor's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Kimber Taylor is licensed in Nevada.

CMS data shows 3,147 Medicare services from Kimber Taylor across 11 procedure codes in 2024, for 281 Medicare patients. Medicare paid $53,527 for them. Every service was in an office.

CMS counts 281 Medicare patients who saw Kimber Taylor in 2024. The largest group is 65 to 74, with 128 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kimber Taylor's median patient age at 71, with 62% women.

In 2024, Kimber Taylor wrote 350 Medicare Part D claims for 141 patients. 91% of them were for generic drugs. CMS names the drug for 195 of them, across 4 drugs with 11 or more claims each, at $3,103 in total drug cost.

Kimber Taylor accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 266 general payments to Kimber Taylor from 42 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 94% of the total. Daiichi Sankyo Inc. paid the most, $683.